BLU 25 Pill - white round, 5mm
Generic Name: avapritinib
Pill with imprint BLU 25 is White, Round and has been identified as Ayvakit 25 mg. It is supplied by Blueprint Medicines Corporation.
Ayvakit is used in the treatment of Systemic Mastocytosis; Gastrointestinal Stromal Tumor and belongs to the drug class multikinase inhibitors. Ayvakit 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BLU 25
Ayvakit
- Generic Name
- avapritinib
- Imprint
- BLU 25
- Strength
- 25 mg
- Color
- White
- Size
- 5.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Blueprint Medicines Corporation
- National Drug Code (NDC)
- 72064-0125
See also:
Prilosec
Prilosec (omeprazole) is used to treat symptoms of GERD and other conditions caused by excess ...
Prevacid
Prevacid is used to treat and prevent stomach and intestinal ulcers. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Gastrocrom
Gastrocrom is used for inflammatory bowel disease, systemic mastocytosis
Midostaurin
Midostaurin is used for acute myeloid leukemia, systemic mastocytosis
Cromolyn
Cromolyn is used for asthma, maintenance, inflammatory bowel disease, systemic mastocytosis
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Lansoprazole
Lansoprazole is used to treat stomach and intestinal ulcers, erosive esophagitis and ...
More about Ayvakit (avapritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.